Atypical Antipsychotics and the Risk of Falls and Fractures Among Older Adults: An Emulation Analysis and an Evaluation of Additional Confounding Control Strategies: Erratum

Journal of Clinical Psychopharmacology: June 2017 - Volume 37 - Issue 3 - p 322
doi: 10.1097/JCP.0000000000000712
Erratum

The authors of an article published in the April 2017 issue of the Journal of Clinical Psychopharmacology requested clarification of the “Author Disclosure Information” on page 167.

This information should read as follows:

“Author Disclosure Information

All coauthors are employees of Janssen Research & Development, LLC, a company that conducts research on schizophrenia and manufactures and sells antipsychotics. The authors declare no other conflicts of interest.”

Back to Top | Article Outline

REFERENCE

Ramcharran D, Qiu H, Schuemie MJ, et al. Atypical antipsychotics and the risk of falls and fractures among older adults: An emulation analysis and an evaluation of additional confounding control strategies. J Clin Psychopharmacol. 2017;37:162–168.
Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.